Literature DB >> 18557790

Interleukin-15 stimulates macrophages to activate CD4+ T cells: a role in the pathogenesis of rheumatoid arthritis?

René Rückert1, Katja Brandt, Martin Ernst, Kathleen Marienfeld, Elena Csernok, Claudia Metzler, Vadim Budagian, Elena Bulanova, Ralf Paus, Silvia Bulfone-Paus.   

Abstract

Interleukin-15 (IL-15) is a proinflammatory cytokine that is overexpressed in rheumatoid arthritis (RA), a disease characterized by activation of monocytes/macrophages (MPhi), and by expansion of autoreactive CD4(+) T cells. We hypothesized that IL-15 plays a major role for this expansion of CD4(+) T cells and modulates the phenotype of monocytes/MPhi and their interaction with CD4(+) T cells. Here, we show that IL-15 enhances the proliferation of CD4(+) T cells from patients with RA in peripheral blood mononuclear cell cocultures. To further dissect the underlying mechanisms, we employed MPhi from IL-15(-/-) or IL-15 transgenic mice. These were induced to differentiate or were stimulated with IL-15. Here we show that addition of IL-15 during differentiation of MPhi (into 'IL-15MPhi') and overexpression of IL-15 by MPhi from IL-15(tg) mice leads to increased levels of major histocompatibility complex class II expression. This resulted in enhanced stimulation of antigen-specific CD4(+) T cells in vitro and was accompanied by reduced messenger RNA expression in MPhi for immunosuppressive SOCS3. The proliferation rates of IL-15MPhi and IL-15(tg)MPhi were high, which was reflected by increased p27(Kip1) and reduced p21(Waf1) levels. In view of high serum and synovial levels of IL-15 in patients with RA, our data suggest the possibility that this excess IL-15 in RA may stimulate monocytes/MPhi to activate the characteristic autoreactive CD4(+) T cells in RA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18557790      PMCID: PMC2632696          DOI: 10.1111/j.1365-2567.2008.02878.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

Review 1.  Interleukin 15: biology and relevance to human disease.

Authors:  T A Fehniger; M A Caligiuri
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

2.  IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro.

Authors:  Wanda Niedbala; Xiaoqing Wei; Foo Y Liew
Journal:  Eur J Immunol       Date:  2002-02       Impact factor: 5.532

3.  Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis.

Authors:  I B McInnes; B P Leung; R D Sturrock; M Field; F Y Liew
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

4.  CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity.

Authors:  D Schmidt; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

5.  Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes.

Authors:  María-Eugenia Miranda-Carús; Marta Benito-Miguel; Alejandro Balsa; Tatiana Cobo-Ibáñez; Carlos Pérez de Ayala; Dora Pascual-Salcedo; Emilio Martín-Mola
Journal:  Arthritis Rheum       Date:  2006-04

6.  Mouse macrophage development in the absence of the common gamma chain: defining receptor complexes responsible for IL-4 and IL-13 signaling.

Authors:  A Andersson; S M Grunewald; A Duschl; A Fischer; J P DiSanto
Journal:  Eur J Immunol       Date:  1997-07       Impact factor: 5.532

7.  Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines.

Authors:  M Kondo; D C Scherer; T Miyamoto; A G King; K Akashi; K Sugamura; I L Weissman
Journal:  Nature       Date:  2000-09-21       Impact factor: 49.962

8.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

9.  Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.

Authors:  J Nourse; E Firpo; W M Flanagan; S Coats; K Polyak; M H Lee; J Massague; G R Crabtree; J M Roberts
Journal:  Nature       Date:  1994-12-08       Impact factor: 49.962

10.  Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Authors:  M K Kennedy; M Glaccum; S N Brown; E A Butz; J L Viney; M Embers; N Matsuki; K Charrier; L Sedger; C R Willis; K Brasel; P J Morrissey; K Stocking; J C Schuh; S Joyce; J J Peschon
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

View more
  22 in total

1.  IL-15 regulates susceptibility of CD4+ T cells to HIV infection.

Authors:  Lara Manganaro; Patrick Hong; Matthew M Hernandez; Dionne Argyle; Lubbertus C F Mulder; Uma Potla; Felipe Diaz-Griffero; Benhur Lee; Ana Fernandez-Sesma; Viviana Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-26       Impact factor: 11.205

Review 2.  New treatments for inflammatory rheumatic disease.

Authors:  Carlo Selmi; Elena Generali; Marco Massarotti; Gerolamo Bianchi; Carlo A Sciré
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

3.  Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats.

Authors:  Liesu Meng; Wenhua Zhu; Congshan Jiang; Xiaojing He; Weikun Hou; Fang Zheng; Rikard Holmdahl; Shemin Lu
Journal:  Arthritis Res Ther       Date:  2010-05-25       Impact factor: 5.156

4.  Novel roles for IL-15 in T cell survival.

Authors:  Erik L Brincks; David L Woodland
Journal:  F1000 Biol Rep       Date:  2010-09-08

Review 5.  Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis.

Authors:  Jie Huang; Xuekun Fu; Xinxin Chen; Zheng Li; Yuhong Huang; Chao Liang
Journal:  Front Immunol       Date:  2021-07-09       Impact factor: 7.561

6.  IL-15 augments TCR-induced CD4+ T cell expansion in vitro by inhibiting the suppressive function of CD25 High CD4+ T cells.

Authors:  Tom L Van Belle; Hans Dooms; Tom Boonefaes; Xiao-Qing Wei; Georges Leclercq; Johan Grooten
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

7.  Deficiency of interleukin-15 enhances susceptibility to acetaminophen-induced liver injury in mice.

Authors:  Hsein-San Hou; Ching-Len Liao; Huey-Kang Sytwu; Nan-Shih Liao; Tien-Yu Huang; Tsai-Yuan Hsieh; Heng-Cheng Chu
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

8.  A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.

Authors:  Anupa Kamat; Vikas Misra; Edana Cassol; Petronela Ancuta; Zhenyu Yan; Cheng Li; Susan Morgello; Dana Gabuzda
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

9.  Arthritis is associated with T-cell-induced upregulation of Toll-like receptor 3 on synovial fibroblasts.

Authors:  Wenhua Zhu; Liesu Meng; Congshan Jiang; Xiaojing He; Weikun Hou; Peng Xu; Heng Du; Rikard Holmdahl; Shemin Lu
Journal:  Arthritis Res Ther       Date:  2011-06-27       Impact factor: 5.156

Review 10.  A Tale of Two Immune Cells in Rheumatoid Arthritis: The Crosstalk Between Macrophages and T Cells in the Synovium.

Authors:  Jiajie Tu; Wei Huang; Weiwei Zhang; Jiawei Mei; Chen Zhu
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.